Edges in Network
| Network | GSE25055_egf1520 - GSE25055 - SiGN-BN HC+Bootstrap |
| Network Description | Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | BCL2L1 |
| Upstream (Parents) |
|---|
| (<<) CASP8 → BCL2L1 |
| (<<) CPD → BCL2L1 |
| (<<) CSNK1A1 → BCL2L1 |
| (<<) DAZAP2 → BCL2L1 |
| (<<) DHX9 → BCL2L1 |
| (<<) ELF1 → BCL2L1 |
| (<<) EPHB4 → BCL2L1 |
| (<<) GNA13 → BCL2L1 |
| (<<) HPCAL1 → BCL2L1 |
| (<<) HSPA8 → BCL2L1 |
| (<<) JUND → BCL2L1 |
| (<<) KRT6B → BCL2L1 |
| (<<) MAPK14 → BCL2L1 |
| (<<) MAT2A → BCL2L1 |
| (<<) MCL1 → BCL2L1 |
| (<<) MLX → BCL2L1 |
| (<<) NOL9 → BCL2L1 |
| (<<) NOTCH1 → BCL2L1 |
| (<<) PRKCDBP → BCL2L1 |
| (<<) RAB5A → BCL2L1 |
| (<<) SH3GLB2 → BCL2L1 |
| (<<) STAT3 → BCL2L1 |
| (<<) STK4 → BCL2L1 |
| (<<) TCF7L1 → BCL2L1 |
| (<<) THY1 → BCL2L1 |
| (<<) TSPAN3 → BCL2L1 |
| (<<) UBE2D3 → BCL2L1 |
| (<<) UBE2N → BCL2L1 |
| (<<) YWHAE → BCL2L1 |
| (<<) YWHAZ → BCL2L1 |
| Downstream (Children) |
|---|
| BCL2L1 → ADRBK1 (>>) |
| BCL2L1 → AKT1 (>>) |
| BCL2L1 → BPGM (>>) |
| BCL2L1 → CAMKK2 (>>) |
| BCL2L1 → CRK (>>) |
| BCL2L1 → DUSP1 (>>) |
| BCL2L1 → FKSG2 (>>) |
| BCL2L1 → FOXO3 (>>) |
| BCL2L1 → GNA11 (>>) |
| BCL2L1 → GNB2L1 (>>) |
| BCL2L1 → GRIN2D (>>) |
| BCL2L1 → INPPL1 (>>) |
| BCL2L1 → INVS (>>) |
| BCL2L1 → KLF4 (>>) |
| BCL2L1 → LIPG (>>) |
| BCL2L1 → MYL7 (>>) |
| BCL2L1 → OGFR (>>) |
| BCL2L1 → PDIA3 (>>) |
| BCL2L1 → PDK2 (>>) |
| BCL2L1 → PIK3R3 (>>) |
| BCL2L1 → PRKCD (>>) |
| BCL2L1 → RXRA (>>) |
| BCL2L1 → SMAD3 (>>) |
| BCL2L1 → SOD3 (>>) |
| BCL2L1 → SRC (>>) |
| BCL2L1 → STAT6 (>>) |
| BCL2L1 → ZNF224 (>>) |
